Neonatal size unaffected by gestational diabetes drugs

March 8, 2013
Neonatal size unaffected by gestational diabetes drugs
Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in the March issue of Diabetes Care.

(HealthDay)—Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in the March issue of Diabetes Care.

Helen L. Barrett, M.B.B.S., from the University of Queensland in Herston, Australia, and colleagues examined the association between circulating maternal and neonatal markers of metabolic status (glucose, lipids, C-reactive protein) with infant size at birth in women with gestational diabetes mellitus, where 236 women had been randomly assigned to metformin and 242 had been randomly assigned to insulin.

The researchers found that women treated with metformin had a significantly greater increase in triglycerides at 36 weeks of gestation (21.93 versus 9.69 percent). There were no other differences between treatment groups for maternal or neonatal metabolic markers or neonatal anthropometry. After adjusting for possible confounding variables, including maternal , a birth weight in the >90th percentile was associated with markers of , maternal , and triglycerides, while a birth weight in the <10th percentile was associated with triglycerides.

"There were few differences in circulating maternal and neonatal markers of metabolic status and no differences in measures of anthropometry between the offspring of women treated with metformin and the offspring of women treated with insulin," Barrett and colleagues conclude.

Explore further: Gestational diabetes, obesity impact pregnancy outcomes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gestational diabetes, obesity impact pregnancy outcomes

March 2, 2012

(HealthDay) -- Women with gestational diabetes mellitus (GDM) who are obese have significantly higher odds of adverse pregnancy outcomes, according to findings from the multinational Hyperglycemia and Adverse Pregnancy Outcome ...

Recommended for you

New blood test may better predict gestational diabetes

April 27, 2017

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity ...

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.